Blotter

House appropriations subcommittee proposes increases to NIH budget for FY20

By
May 1, 2019

The U.S. House appropriations subcommittee on Labor, Health and Human Services, Education and Related Agencies debated and amended an appropriations bill for fiscal year 2020.  The bill includes funding for the National Institutes of Health.  If signed into law, the NIH will be appropriated at $41.1 billion, 4% above FY19.  The proposed bill also provides an increase in funding to the National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke, and National Cancer Institute of $3.03 billion, $2.31 billion, and $6.25 billion, respectively.

Institute (full bill text) FY19 enacted (billion) FY20 proposed (billion)
NIGMS $2.87 $3.03
(↑ $0.56 billion above President’s request)
NINDS $2.27 $2.31
(↑ $0.29 billion above President’s request)
NCI $6.14 $6.25
(↑ $1.01 billion above President’s request)
NHLBI $3.49 $3.66
(↑ $0.66 billion above President’s request)
NIAID $5.52 $5.81
(↑ $1.06 billion above President’s request)

The U.S. Senate will also introduce an appropriations bill that includes funding for the NIH in FY20.  Senate Majority Leader Mitch McConnell, R-Ky., has discussed a deal to address the spending caps with House Speaker Nancy Pelosi, D-Calif., and President Donald Trump. If the Senate proposes funding levels that differ from those introduced by the House, both chambers will need to agree on final budget numbers. 

Funding levels proposed in the subcommittee’s bill come in direct contrast with Trump’s FY20 budget request. The president’s budget calls for a 15% decrease to the NIH’s budget, reducing the biomedical research agency by $6 billion below FY19 levels. This reduction in funding falls under spending caps imposed by the Budget Control Act, which legislates sharp cuts in domestic spending to reduce the national debt, currently at $22 trillion. If the U.S. Congress is unable to reach a budget deal to increase the spending caps for nondefense discretionary programs by the end of the fiscal year on Sept. 30, an automatic budget reduction of 9% across all federal agencies will be imposed.

The NIH has received large increases in recent years, providing new investments towards disease-specific research and allowing the agency to increase the number of research grants that it supports. 

The American Society for Biochemistry and Molecular Biology has advocated for increases to the NIH’s budget and will continue to work with the community in support of the biomedical research funding agency.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Policy

Policy highlights or most popular articles

ASBMB honors Lawrence Tabak with public service award
Award

ASBMB honors Lawrence Tabak with public service award

March 26, 2025

He will deliver prerecorded remarks at the 2025 ASBMB Annual Meeting in Chicago.

Summer internships in an unpredictable funding environment
Professional Development

Summer internships in an unpredictable funding environment

March 14, 2025

With the National Institutes of Health and other institutions canceling summer programs, many students are left scrambling for alternatives. If your program has been canceled or delayed, consider applying for other opportunities or taking a course.

Black excellence in biotech: Shaping the future of an industry
Observance

Black excellence in biotech: Shaping the future of an industry

Feb. 28, 2025

This Black History Month, we highlight the impact of DEI initiatives, trailblazing scientists and industry leaders working to create a more inclusive and scientific community. Discover how you can be part of the movement.

ASBMB releases statement on sustaining U.S. scientific leadership
Blotter

ASBMB releases statement on sustaining U.S. scientific leadership

Jan. 16, 2025

The society encourages the executive and legislative branches of the U.S. government to continue their support of the nation’s leadership in science.

ASBMB and advocacy: What we accomplished in 2024
What we do

ASBMB and advocacy: What we accomplished in 2024

Dec. 27, 2024

PAAC members met with policymakers to advocate for basic scientific research, connected some fellow members with funding opportunities and trained others to advocate for science.

‘Our work is about science transforming people’s lives’
Interview

‘Our work is about science transforming people’s lives’

Dec. 17, 2024

Ann West, chair of the ASBMB Public Affairs Advisory Committee, sits down Monica Bertagnolli, director of the National Institutes of Health.